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The behavior of two genetically different molecular clones of visna virus KV1772-kv72/67 and LV1-1KS1 was compared
in vivo and in vitro. On intracerebral inoculation, clone KV1772-kv72/67 induced a similar response in five sheep as has
already been reported with neurovirulent derivates of visna virus. Virus was frequently isolated from blood, cerebrospinal
fluid (CSF), and lymphoid organs and induced characteristic central nervous system (CNS) lesions. A strong humoral immune
response was detected by ELISA, immunoblotting, and neutralization. Six sheep infected with clone LV1-1KS1 showed a
completely different picture. No virus could be isolated from blood or CSF during 6 months of infection. At sacrifice all
organs were virus-negative except the CNS of one sheep. None of the six sheep developed significant neutralizing antibodies
and only low titer antibodies were detected by ELISA and immunoblotting. Minimal CNS lesions were present in one sheep.
The molecular clones were also tested in sheep choroid plexus cells (SCP) and macrophages. In macrophages LV1-1KS1
replicated to a significantly lower titer but induced much more cell fusion than KV1772-kv72/67. The clones replicated
equally well in SCP cells. Thus, these molecular clones of visna virus, which differ only by 1% in nucleotide sequence,
showed a profound difference in replication and pathogenicity both in vitro and in vivo. These results can be used to map
viral genetic determinants important for host–lentivirus interactions. q 1997 Academic Press
INTRODUCTION phage-tropic virus strains rather than lymphotropic
strains (Cheng-Mayer et al., 1989; Sharma et al., 1992).
The causative agent of visna, a meningoencephalomy- Pathological lesions in visna are usually related to the
elitis of sheep, was the first of the lentiviruses to be susceptibility of local macrophages to virus replication
isolated and described (Sigurdsson et al., 1960). Visna (Narayan et al., 1989). In both visna and HIV-1 infections,
has been studied extensively in experimental infection productive viral replication within lung and brain macro-
of Icelandic sheep (reviewed in Pe´tursson et al., 1994), phages reflects tissue pathology. Histiocytes of connec-
with emphasis on pathogenetic mechanisms of lesion tive tissue and Langerhans cells of skin are much less
development in the central nervous system (CNS). These permissive for viral replication and lesions are not ob-
lesions have been reported to be immune-mediated (Na- served (Gendelman et al., 1985; Gendelman and Meltzer,
thanson et al., 1976, 1981) and there is evidence that 1990, for review).
CD8-positive lymphocytes may be the key effector cells Although considerable knowledge has been obtained
(Torsteinsdo´ttir et al., 1992). on host–virus interaction in visna virus infection of
Visna virus is related to human immunodeficiency virus sheep, several questions remain open, which are difficult
type-1 (HIV-1) (Gonda et al., 1985) and the host–virus to tackle because of the complexity of the viral genome.
interactions observed in visna virus infection share sev- The ungulate lentiviruses visna and caprine arthritis en-
eral common features with those observed in the initial cephalitis virus (CAEV) have as other lentiviruses, env,
stages of infection with HIV-1 (Georgsson et al., 1990a). gag, and pol genes that encode structural proteins and
The primary target cells of visna virus infection are cells enzymes. They also have three regulatory genes, vif, tat,
of the monocyte/macrophage lineage and the virus gene and rev, that modulate the viral life cycle in vitro and
expression is a function of maturation of these cells (Nar- probably contribute to clinical latency and pathogenesis
ayan et al., 1982; Gendelman et al., 1986). In infections in vivo. (Davis and Clements, 1989; Saltarelli et al., 1990;
with HIV-1 as well as simian immunodeficiency virus Sonigo et al., 1985; Vigne et al., 1982). Several important
(SIV), neurotropism is apparently associated with macro- questions relating to host–virus interactions in lentiviral
infections such as visna can only be addressed using
well-defined molecular clones. Two infectious molecular1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 354-5673979; E-mail: sibbath@rhi.hi.is. clones of visna virus have been isolated and sequenced,
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FIG. 1. Lineage of visna virus strains following passage through sheep and tissue culture.
i.e., clone KV1772-kv72/67 (Andre´sson et al., 1993) and mine, 100 IU/ml penicillin, 100 IU/ml streptomycin, and
10% normal lamb serum (LS). For maintenance and anti-LV1-1KS1 (Staskus et al., 1991). Both clones have their
origin in a transmission experiment where visna virus gen production the cells were transferred into TC199
medium (Gibco) supplemented with 2 mM glutamine, an-was passaged successively in sheep. Clone KV1772-
kv72/67 was derived from strain KV1772, that was se- tibiotics, and 1% LS or 0.5% fetal calf serum (FCS). Macro-
phage cultures were established as follows: 100 ml oflected for neurovirulence (Fig. 1), (Lutley et al., 1985;
Georgsson et al., 1989) and has already been shown to heparinized blood was collected from normal sheep and
peripheral blood mononuclear cells (PBMC) obtained bybe pathogenic in vitro and in vivo (Andre´sson et al., 1993).
Clone LV1-1KS1 has also been shown to be cytopathic sedimentation on Histopaque-1077 (Sigma) (Bøyum,
1968) were washed repeatedly in PBS and resuspendedin vitro (Staskus et al., 1991) but has not been tested
in vivo previously. With these tools at hand, i.e., a well at 12 1 106 cells/ml in DMEM supplemented with 5 1
1005 M mercaptoethanol and 10% LS. They were thenestablished animal model and two infectious molecular
clones of known nucleotide sequence, we decided to seeded into 4 1 1-ml plastic chamber tissue culture
slides (180 mm2, Permanox, Nunc Inc.). After settling attest the clones in vitro and in vivo and compare their
replication pattern and pathogenicity. This could provide 377 in humidified atmosphere with 5% CO2 for 24 hr,
supernatant and unattached cells were removed and theus with a tool to map out genetic determinants of host –
lentivirus interaction. slide was washed twice with PBS before adding 1 ml of
new growth medium to each chamber. Adherent cells
were further incubated for 7 days before they were in-MATERIALS AND METHODS
fected and identified as macrophages by immunostain-
Cells and culture medium ing with anti-human CD68 (Dako).
Sheep choroid plexus cells (SCP) established as de-
Preparation of virus for infection and antigens
scribed by Pe´tursson and coworkers (1976) were cul-
tured at 377 in humidified atmosphere with 5% CO2 in Visna virus for infection was prepared as follows: 1
liter culture fluid from visna-infected SCP cells was clari-Dulbecco’s MEM (Gibco) supplemented with 2 mM gluta-
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fied by centrifugation at 13,200 g for 15 min. Polyethylene with 5% CO2 . After careful rinsing with PBS, 1 ml of
growth medium was added. Incubation was continuedglycol (PEG 8000), 70 g and 23 g of NaCl were added to
the supernatant and agitated for 1.5 hr at 47 and centri- and supernatants were harvested at 12 hr and then daily
for 6 days p.i., spun at 3000 rpm for 5 min in a Microspinfuged at 5,000 g for 25 min. The pellet was dissolved in
1 ml TNE buffer, titrated, and stored at 0807. 24S Sorvall centrifuge, collected, and stored at0807 until
titrated.Visna virus antigen for ELISA and Western blotting
(WB) was prepared as follows: 1 liter culture fluid from Cytopathic effect. To evaluate the cytopathic effect,
especially the induction of multinucleated giant cells andvisna-infected SCP cells, cultured in TC199 medium sup-
plemented with 0.5% FCS, was clarified by centrifugation expression of viral proteins, tissue culture slides were
harvested daily for 6 days p.i., fixed in alcohol, andat 13,200 g for 15 min. The supernatant was collected
and centrifuged overnight (16 hr) at 14,600 g. The pellet stained with a monoclonal antibody to p25 core protein
of the visna virus and/or Giemsa. For immunostainingwas resuspended in 1 ml TNE buffer (100 mM NaCl, 10
mM Tris–HCl, pH 7.4, 1 mM EDTA), mixed with 1 ml high we used Extravidin peroxidase staining kit (Sigma) with
diaminobenzidine (DAB) as substrate. Cells weresalt buffer (TNE buffer with 5.3 M NaCl), and the mixture
kept at room temperature for 30 min, diluted 1:1 with counted in an area of 1.28 mm2 and the percentage of
multinucleated syncytial cells was calculated.Tris–HCl–EDTA buffer (20 mM Tris–HCl, pH 7.4, 1 mM
EDTA), and pelleted at 100,000 g for 2 hr. The pellet was
resuspended in 1 ml TNE buffer, aliquoted, and frozen Specimen collection and tests
at 0807 until use (Traul et al., 1975).
Blood. Group I (sheep nos. 1921–1925): Blood was
Molecular clones collected weekly for the first 8 weeks p.i. and then every
other week. Group II and III (sheep nos. 1947–1949 andThe molecular clone KV1772-kv72/67 (Andre´sson et
1958–1961): Blood was collected weekly for the first 4al., 1993) is derived from visna strain KV1772, a plaque-
weeks and then every other week up to 8 weeks andpurified biological clone (Fig. 1), which was selected for
then monthly. The following tests were done: (a) Virusneurovirulence by serial passage of strain K1514 in
isolation from buffy coat: Heparinized blood was centri-sheep (Lutley et al., 1985; Georgsson et al., 1989). LV1-
fuged for 25 min at 400 g, the buffy coat collected by1KS1 was reported to be derived from 1514 (Staskus et
pipetting, red blood cells lysed with lysing buffer (9 partsal., 1991) but sequencing data from a number of virus
0.83% NH4Cl / 1 part 0.17% Tris–HCl, pH 7.2), the buffyisolates indicates that it is most closely related to K796,
coat washed three times in PBS, and inoculated into 3a virus appearing early in the lineage of visna virus
tubes of SCP cells (0.1 ml per tube). (b) Virus titration instrains (Fig. 1) (Valgerdur Andre´sdo´ttir, unpublished re-
cell cultures: Tenfold dilutions of supernatants weresults).
made in TC199 medium supplemented with 1% LS. One
milliliter of each dilution was added to each of four glassAnimals and infection
test tubes with SCP culture. The test tubes were put on
Icelandic sheep, 1 and 11/2 years old, were infected by roller drums for at least 21 days when final readings of
inoculation into the left cerebral hemisphere according to cytopathic effects were made. Titrations were also done
standard procedure (Pe´tursson et al., 1976). in 96-well flatbottomed tissue culture plates (Nunclon
Group I. Five sheep (Nos. 1921–1925) were infected Delta) with 1 1 104 SCP cells in DMEM growth medium,
with 0.4 ml of clone KV1772-kv72/67, titer 108.5 TCD50 per 100 ml in each well, and incubated in humidified atmo-
ml, and sacrificed 6 months post infection (p.i.). sphere with 5% CO2 at 377 for 2 days. Then growth me-
Group II. Two sheep (Nos. 1948 and 1949) were in- dium was substituted with 100 ml maintenance medium
fected with 0.4 ml of the clone LV1-1KS1, titer 108.5 TCD50 supplemented with 1% normal lamb serum. Tenfold dilu-
per milliliter. The sheep are still under observation. tions were made in DMEM maintenance medium and
Group III. Four sheep (Nos. 1958–1961) were infected 100 ml of each dilution added to each of four wells. The
with 0.4 ml of the clone LV1-1KS1, titer 108.0 TCD50 per culture plates were incubated in humidified atmosphere
milliliter, and sacrificed 6 months p.i. with 5% CO2 at 377 for at least 4 weeks when final read-
ings of cytopathic effects were made. Calculation of the
Infection of macrophages and SCP cells
LD50 titer was done by the Reed–Muench method
(Hawkes, 1979). (c) ELISA: A slightly modified methodViral replication. Macrophages and SCP cell cultures
on tissue culture chamber slides (Nunc) were infected from Houwers et al. (1982) was used. Microtiter plates
(Dynatech-Immunlon) were coated with 100 ml of 1/400with different multiplicities of infection (m.o.i.), from 0.2
to 10 in 0.5-ml vol to each chamber. One uninfected dilution of visna ELISA antigen in 0.05 M carbonate/bicar-
bonate buffer, pH 9.6, 1 hr at 377 and then overnight atchamber on each slide served as a control. The slides
were incubated for 4 hr at 377 in humidified atmosphere 47. Threefold dilutions of serum were made starting with
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dilution 1/200 and unbound material was removed by lungs (1 block from each lobe), spleen, lymph nodes
(cervical, mediastinal, and mesenterial), and bone mar-washing with PBS containing 0.05% Tween 20. Rabbit
anti-goat IgG conjugated to horseradish peroxidase row. The samples were fixed in 10% phosphate-buffered
formalin, embedded in paraffin, and sections cut at 3–5(Sigma A4174) was used at a dilution of 1/4000 and
bound antibody detected with H2O2/o-phenylenediamine mm. The brain was cut at nine standard levels (Pe´tursson
et al., 1976). The sections were routinely stained withdihydrochloride (OPD) (Dako) in phosphate-citrate buffer
at pH 5.0. The reaction was stopped after 30 min with haematoxylin eosin (H.E.) but in addition lymphoid tis-
sues were stained with Giemsa, and selected sections75 ml per well of 0.04% H2SO4 and the optical density
read at 492 nm in a Titertek Multiskan Plus (Flow Labora- from the CNS with Klu¨ver–Barrera stain for myelin and
Bodian’s stain for axons. The brain lesions were gradedtories). (d) Neutralization test: One hundred TCD50 of the
virus of infection was used and the virus-serum mixture on a scale 0–6 according to Pe´tursson et al. (1976) with
slight modification: 1, definite minimal lesions (two toincubated at 47 for 48 hr (Gudnado´ttir and Pa´lsson, 1965).
Four tubes of SCP cells were used for each serum dilu- three of the following histological changes: periventricu-
lar inflammation, perivascular cuffs in white and/or greytion and the test was read after 21 days. (e) Immunoblots:
SDS–PAGE was done in the Mini-protean II system from matter, glial nodules, leptomeningitis, inflammation of the
choroid plexus); 2, similar to 1 but more intense or wide-Bio-Rad according to manufacturer’s instructions. Con-
centrated visna virus antigen (100 ml) boiled with 100 ml spread; 3, subconfluent but extensive periventricular le-
sions with some involvement of the white matter; 4, ex-21 Laemmli sample buffer (125 mM Tris buffer with 5%
mercaptoethanol, 2% SDS, pH 6.8) was applied to a 4.5% tensive confluent periventricular inflammation with some
confluent involvement of the white matter; 5, as in 4 plusstacking gel and a 14% separation gel and blotted onto
nitrocellulose. This was followed by a transfer to a nitro- small necrotic lesions; 6, most severe cases of visna
with more extensive necrosis. The lesions were assignedcellulose membrane using the Mini Transblot system
(Bio-Rad), according to manufacturer’s instructions. an intermediate grade, i.e., 0.5, if lesions were not ob-
served in all main areas.Transfer was carried out for 90 min in 25 mM Tris–gly-
cine buffer, pH 8.8, containing 20% methanol, at 100 V
and 250 mA. After the transfer the nitrocellulose mem- RESULTS
brane was blocked for 1 hr at room temperature with
Virus isolations0.1 M Tris–HCl-buffered saline, pH 7.8, containing 0.5%
Tween 20. The serum and conjugate was diluted in 0.1 The main features of the host response to infection
M Tris–HCl-buffered saline, pH 7.8, containing 0.1% with the two clones are summarized in Table 1. Infection
Tween 20 (TBS-T). After blocking, the nitrocellulose was was established in all sheep in group I, infected with
cut into strips and incubated with serum samples diluted KV1772-kv72/67, as evidenced by virus isolation and neu-
1/500 overnight in 47 on a roller. Rabbit anti-goat IgG tralizing antibodies. Viremia persisted to the end of the
conjugated to horseradish peroxidase (Sigma A4174) experiment. Virus was isolated from blood and lymphoid
was used at a dilution of 1/10,000 for 1 hr at 377. The tissue of all sheep and from the CNS of all but one.
blots were washed extensively in TBS-T between each Viremia was not detected in sheep in groups II and III,
step. The ECL system from Amersham was used for de- infected with LV1-1KS1, during an observation period of
veloping the blots. Prestained molecular weight markers 6 months and those still under observation (1948 and
were used in the immunoblotting. 1949) were negative 1 year p.i. The only positive virus
CSF. CSF was collected 4, 12, or 16 weeks p.i. and at isolation in group III was from the CNS (choroid plexus
sacrifice for cell counts and virus isolation. For virus and medulla) of one sheep. Lymphoid tissue and lungs
isolation CSF was inoculated into three tubes of SCP (not shown) were negative. The group III virus isolates
cells (0.3 ml per tube). were identified as LV1-1KS1 by PCR and sequencing of
nucleotides 7600–7700 in the env gene.
Collection of tissues and testing at sacrifice
Antibody response
Virus isolation. The following tissues were tested for
presence of infectious virus by explantation (Pe´tursson All sheep in group I developed neutralizing antibodies.
The titers varied considerably, i.e., from 32 to 2,048 6et al., 1976): choroid plexus, cerebellum, medulla, spinal
cord (cervical, thoracic, and lumbar), spleen, cervical, months p.i. (Table 1). Except for borderline titers of 4 in
two sheep, neutralizing antibodies were not detected inmediastinal and mesenteric lymph nodes, lungs (1 sam-
ple from each lobe), and bone marrow. group II and III 6 months p.i. (Table 1). With the ELISA
method visna-specific antibodies were found in all sheepHistology. The following organs were sampled and
processed for histological examination: Brain (left half), in group I (Fig. 2). Low titers were detected 2 weeks p.i.
but at 6–8 weeks titers had reached a plateau of 48,600spinal cord (midcervical, midthoracic, and midlumbar),
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TABLE 1
Virus Isolation, Neutralizing Antibody Titer, Cells in CSF, and Histological Grade of CNS Lesions
Frequency of virus isolation Antibodies CSF cells CNS
Blood CNS and CSF Lymphoida tissue Neutralizingb antibodies Firstc count Lastc count Histologicald grade
Group Ie
1921 7/17 4/9 1/5 2048 1517 137 3.0
1922 9/17 4/9 3/5 128 194 110 2.5
1923 5/17 0/9 2/5 32 10 78 0.5
1924 10/17 4/9 3/5 512 462 70 3.5
1925 7/17 1/9 2/5 256 15 36 2.0
Group IIe
1948 0/11 0/3 ND 0 214 21 ND
1949 0/11 0/2 ND 0 45 22 ND
Group IIIe
1958 0/11 0/9 0/5 4 11 5 0
1959 0/11 0/8 0/5 0 31 14 0
1960 0/11 0/9 0/5 4 86 5 0.5
1961 0/11 2/9 0/5 0 121 6 {
a Spleen, bone marrow, cervical, mediastinal, and mesenteric lymph nodes.
b Titers at 6 months postinfection (p.i.).
c Cells/ml, first (4 weeks p.i. except 1948 13 weeks p.i.) and last values 6 months p.i.
d Grading on a scale 0–6 (Pe´tursson et al., 1976).
e Group I, infected with KV1772 kv72/67. Group II and III infected with LV1-1KS1.
to 145,800 and remained stable within a variation of one dilution until the end of the 6-month period of observation
(Fig. 2). The sheep in group II, which are still being ob-threefold dilution until the end of the experiment. Visna-
specific antibodies were detected by ELISA in all sheep served, showed an ELISA titer of 600 1 year p.i., whereas
tests for neutralizing antibodies were still negative atin group II and III (Fig. 2). The titers were much lower
than in group I and were detected later, i.e., at 3–4 weeks that timepoint (data not shown). In immunoblots a strong
reaction to the main antigenic proteins of the virus, i.e.,p.i. They reached a plateau of 600 to 5,400 8 weeks p.i.
and stayed at that level with a variation of one threefold Gag p25, p16, and the envelope glycoproteins gp135 and
FIG. 2. The time course of antibody response measured by ELISA. (n) Group 1 (sheep 1921–1925 infected with KV1772-kv72/67). Mean, maximum,
and minimal value of serum dilution. (s) Group II and III (sheep 1948, 1949 and 1958–1961 infected with LV1-1KS1). Mean, maximum, and minimal
value of serum dilution.
AID VY 8428 / 6a29$$$383 02-18-97 14:23:06 viras AP: Virology
375MOLECULAR CLONES OF MVV COMPARED
FIG. 3. Antibody reaction to visna virus Env and Gag protein in immunoblots. Pairs of serum, negative and week 24 p.i. from: (A) sheep 1921–
1925 infected with KV1772-kv72/67; (B) sheep 1948, 1949, and 1958–1961 infected with LV1-1KS1.
gp44, was observed in sheep in group I (Fig. 3). The cyte zones of lymph nodes and spleen, was somewhat
more prominent in sheep infected with clone KV1772-sheep in groups II and III showed much fainter reactions
but all reacted to some viral proteins. Serum from 1948, kv72/67 than clone LV1-1KS1. A relatively mild verminous
pneumonia was found in all sheep.1949, 1960, and 1961 bound clearly to p25, whereas se-
rum from 1958 and 1959 showed a stronger reaction to
p16 and gp44 (Fig. 3). Infection in vitro
Virus replication. Both clones showed a similar replica-Pathology
tion pattern and titer in SCP cells during infection (Fig.
5). The same pattern was seen for different m.o.i. Follow-CSF. Definite pleocytosis of the CSF was present in
three sheep in group I 4 weeks p.i. and in all 6 months ing an initial lag period of 24 hr the titers rose abruptly
within the next 12 hr to a titer of 104 TCID50 per milliliter.p.i. The highest values were observed in two sheep 4
weeks p.i., whereas the increase in the number of cells This was followed by a slower rise in titers, reaching a
peak of 107 TCID50 per milliliter 4 days p.i. Subsequentlyin CSF was mild to moderate 6 months p.i. (Table 1). A
modest pleocytosis of the CSF was detected in both a gradual fall in titers at the end of the 6-day period was
observed. As a rule the infection process of SCP cells issheep of group II and in three of four in group III 4 weeks
p.i. Six months p.i. the number of cells in the CSF was faster than in macrophages and proceeds quicker to a
total destruction of the cell layer. In macrophage cultureswithin the normal range in both groups (Table 1).
Histopathology of the CNS. Definite visna lesions were a distinct difference in replication pattern and titers be-
tween the clones was observed (Fig. 6). Clone KV1772-found in the brain of all sheep in group I. They varied in
severity from minimal to relatively severe, i.e., grade 0.5 kv72/67 replicated to a higher titer, showing an earlier
rise in titers than clone LV1-1KS1 and rose to a peakto 3.5 on a scale of 0–6 (Table 1). Furthermore a mild
meningitis was found in the spinal cord in two sheep titer of 107 TCID50 per milliliter within 4 to 5 days p.i. It
stayed at that level with some fluctuation for the 7-dayaccompanied by a discrete inflammatory infiltration in
the posterior columns of the cervical cord in one of them. period of observation with a gradual fall toward the end.
Clone LV1-1KS1 on the other hand showed a similarIn group III only one sheep showed definite but minimal
lesions in the brain (Table 1). The brain lesions in group replication pattern as clone KV1772-kv72/67 but the titers
were consistently approximately two logs lower (Fig. 6).I showed a typical topographical pattern and character.
They consisted mainly of periventricular inflammation, Infection of macrophages with the two clones results in
very similar replication patterns and difference in titerssometimes extending into the adjacent white matter and
leading in the most severe cases to confluent inflamma- regardless of m.o.i.
Cytopathic effect. The main difference in the cytopathiction accompanied by liquefaction necrosis (Fig. 4). Occa-
sional small foci of primary demyelination with some effect of the clones was seen in macrophage cultures.
With clone LV1-1KS1, multinucleated syncytia were de-preservation of axons were observed in one case. A mild
to moderate leptomeningitis was present. Inflammatory tected earlier, i.e., on Day 1 p.i., and they were more
numerous than in cultures infected with clone KV1772-infiltration of the choroid plexus was commonly ob-
served, occasionally very prominent with formation of kv72/67. The most striking difference was the appear-
ance of huge syncytia of multinucleated giant cells inactive lymphoid follicles (Fig. 4). The inflammatory infil-
trates consisted mainly of lymphocytes with some admix- cultures infected with LV1-1KS1, which were detected at
Day 3 p.i., but were most prominent on Day 4. Theseture of macrophages and plasma cells and rare multinu-
cleated giant cells were present in one case. The gray cells extended over considerable areas of low-power mi-
croscopic fields and had an extensive cytoplasma withmatter was spared except for some glial scarring at the
site of inoculation. Hyperplasia, usually of the B-lympho- numerous, widely distributed clusters of several dozens
AID VY 8428 / 6a29$$$383 02-18-97 14:23:06 viras AP: Virology
376 TORSTEINSDO´TTIR ET AL.
FIG. 4. Pathology. (A–C) Infection with clone KV1772-kv72/67. (D–F) Infection with clone LV1-1KS1. (A) Intense periventricular inflammation
extending into adjacent neuroparenchyma. (D) Discrete periventricular inflammation. (B) Confluent inflammation in the white matter accompanied
by destruction of the tissue. (E) Intact white matter. (C) Intense inflammation of choroid plexus with lymph follicle. (F) Discrete inflammatory infiltration
of choroid plexus. H.E., bar, 50 mm.
of nuclei (Fig. 7). With KV1772-kv72/67, the giant cells with clone LV1-1KS1 stained either weakly or not at all
with the anti-viral monoclonal antibody (Fig. 7).were in general smaller with approximately 5–10 nuclei.
An occasional large giant cell with several dozen of nu-
clei was observed (Fig. 7), but cells of comparable size DISCUSSION
to those observed in cultures infected with clone LV1-
1KS1 were not present. By immunostaining, viral antigen Our in vivo experiments with the two molecular clones
KV1772-kv72/67 and LV1-1KS1 revealed a profound dif-was detected, mainly in some giant cells, on Day 2 in
cultures infected with both clones. The intensity of stain- ference in the host response to intracerebral infection
of sheep. Clone KV1772-kv72/67 induced a typical hosting appeared to be similar on Day 2 and 3 p.i. On Day
4 p.i., however, the intensity of staining was distinctly response as has already been described in numerous
experiments with uncloned visna virus (reviewed in Pe´t-stronger in cultures infected with KV1772-kv72/67 (Fig.
7). The huge giant cells observed in cultures infected ursson et al., 1989), with a biologically cloned neuroviru-
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FIG. 5. The kinetics of virus replication in sheep choroid plexus cells, m.o.i.  0.8. (j) Cells infected with LV1-1KS1. (h) Cells infected with
KV1772-kv72/67.
lent strain (Georgsson et al., 1989), and in a previous pattern. Viremia was not detected in the four sheep ob-
served for a 6-month period and the same applies toexperiment with the same molecular clone (Andre´sson
et al., 1993). Thus all the sheep in this experiment in- those two that have been observed for 1 year p.i. The
only positive virus isolation from the LV1-1KS1-infectedfected with clone KV1772-kv72/67 were viremic 4 weeks
p.i. and developed antibodies in the first weeks of infec- sheep was from the CNS of one sheep at sacrifice. Neu-
tralizing antibodies were not detected in four of six sheeption. Virus was recovered from various organs at sacrifice
and typical visna lesions (reviewed in Georgsson, 1990b) and the titers in the two positive sheep were of borderline
values. However, the low titers of ELISA antibodies andwere detected in the CNS. Pleocytosis of the CSF was
detected in all sheep but one. The individual variation in faint but definite reaction to Gag or Env antigens in immu-
noblotting show that all six sheep were infected. Minimalthe host response observed, e.g., severity of CNS lesions
and pleocytosis of the CSF, was as would be expected visna lesions were detected in one of four sheep at sacri-
fice 6 months p.i., whereas the modest pleocytosis of thein outbred animals. The six sheep infected with the mo-
lecular clone LV1-1KS1 showed a completely different CSF detected 1 month p.i. was not found at sacrifice,
FIG. 6. The kinetics of virus production in macrophages, m.o.i.  10. (j) Cells infected with LV1-1KS1. (h) Cells infected with KV1772-kv72/67.
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FIG. 7. Cytopathic effect in macrophages. Macrophage cultures 4 days p.i. (A and B) Infection with clone KV1772-kv72/67. (C and D) Infection
with clone LV1-1KS1. (A) Several multinucleated giant cells. Intense staining of the giant cells (long arrows) except the two largest, and of rounded,
spindle-formed (short arrows) and spider-like cells. (B) Higher magnification of a syncytical giant cell with several dozens of nuclei. Immunostaining
for viral antigen negative (phase contrast). (C) Huge syncytial giant cells extending over most of this low power field. The cytoplasm is unstained
and contains scattered clusters of nuclei. In between, smaller giant cells with distinct staining (arrows). (D) Higher magnification of parts of the
giant cells with clusters of nuclei (phase contrast anti-p25, avidin-biotin immunostaining; bar, 200 mm).
possibly an indication of a self-limiting CNS infection. phage lineage are the main target cells of visna virus
(Narayan et al., 1982; Gendelman et al., 1986).Both the low frequency of virus isolation and low antibody
titers demonstrate that LV1-1KS1 has much less prolifer- The virus strain KV1772 from which molecular clone
KV1772-kv72/67 was isolated was selected for increasedative capacity in vivo than KV1772-kv72/67. We have pre-
viously demonstrated that there is a correlation between neurovirulence and is distinctly more neurovirulent than
strain K796, the parent of molecular clone LV1-1KS1.frequency of virus isolation and severity of CNS lesions
(Pe´tursson et al., 1976). However, the difference in proliferation in macrophages
between the two clones may not correlate with a differ-Our in vitro results of the replication pattern of these
two molecular clones in two different cell culture sys- ence in neurovirulence, since both parent strains grow
well in macrophages.tems, i.e., SCP cells and macrophages, indicate that
there is a correlation between replication in macro- Interestingly, the capacity to induce syncytial giant
cells in vitro did not correspond to the pathogenicity ofphages and pathogenicity in vivo. Both clones showed a
similar replication pattern and titer in SCP cells, which these two molecular clones in vivo. Thus, the clone LV1-
1KS1, which was almost nonpathogenic in vivo, inducedwas comparable to earlier kinetic studies with uncloned
visna virus strains in this cell culture system (Thormar, syncytia to a distinctly greater extent than the pathogenic
clone KV1772-kv72/67. This is in contrast to findings in1965). In the macrophage cultures, however, clone
KV1772-kv72/67 replicated to a considerably higher titer HIV-1 infection where nonsyncytia inducing macrophage
tropic strains are prevalent in early stages of infection butthan clone LV1-1KS1. The correlation between the in vivo
pathogenicity and the in vitro replication in macrophages are replaced by syncytia inducing T-cell tropic variants
during progression to disease (Asjo¨ et al., 1986; Ters-is consistent with earlier findings with uncloned visna
virus strains showing that cells of the monocyte/macro- mette et al., 1988; Fouchier et al., 1996). The induction
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beinn Reginsson for expert technical help. This work was supportedof huge giant cells by LV1-1KS1 is probably due to fusion
in part by The Research Fund of the University of Iceland.from without, which enveloped viruses can induce in the
absence of replication (Clavel and Charneau 1994). Visna
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